1st Edition

Foundation, Architecture, and Prototyping of Humanized AI A New Constructivist Approach

By Mark Chang Copyright 2023
384 Pages 84 Color & 5 B/W Illustrations
by Chapman & Hall

384 Pages 84 Color & 5 B/W Illustrations
by Chapman & Hall

384 Pages 84 Color & 5 B/W Illustrations
by Chapman & Hall

Humanized AI (HAI), emerging as the next of the AI waves, refers to artificial social beings that are very close to humans in various aspects, beings who are machine-race humans, not digital slaves. Foundation, Architecture, and Prototyping of HAI deploy a novel smalldata approach to vertically explore the spectrum of HAI. Different from the popular big-data philosophy that is based on the... Read more

Part 1: Philosophy of Humanized AI in Plain Language

Chapter 1 The Human-Machine World to Create: Humanized AI

Chapter 2 The World We Live in and The World in Our Eyes

Chapter 3 The World in Our Mind: Fundamental Laws and Principles

Chapter 4 The World to Learn: Cognition and Learning

Part 2: Humanized AI and Its Approaches

Chapter 1 A Brief History of AI and Machine-Learning Methods

Chapter 3 Existing Approaches to Humanized AI

Chapter 4 New Approach To Humanized AI

Part 3: Architecture of Humanized AI

Chapter 1 Three Worlds and Virtual Reality

Chapter 2 First Designer Stance

Chapter 3 Dynamic Knowledge Representation

Chapter 4 Attention Mechanism and Attentive World

Chapter 5 Learning Mechanism and Knowledge Discovery

Chapter 6 Adaptive Response Mechanism

Chapter 7 Effective Teaching

Part 4: Prototyping Agents - Zda and Lia

Chapter 1 Functional and Logic Specifications

Chapter 2 Modularization of Humanized AI Architecture

Chapter 3 Implementations of Innate Mechanisms

Chapter 4 Miscellaneous

Glossary

Appendix: Tutorial to Common Methods for Narrow AI

References

 

Biography

Mark Chang, PhD, is the founder of AGInception and an adjunct professor of Biostatistics at Boston University. He is an elected fellow of the American Statistical Association, a co-founder of the International Society for Biopharmaceutical Statistics. He previously held various positions in pharmaceutical companies, including Scientific Fellow, executive Director, and Senior Vice President. He is an adaptive design expert and has extensive knowledge in AI for clinical trials. He has published 12 books on artificial intelligence & machine learning, adaptive clinical trial designs, biostatistics, and scientific principles.